Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

Clinical trial NCT07532824 · RECRUITING

Trial details

NCT number: NCT07532824
Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AML Proton Therapy MDS and AML Prior to Allogeneic SCT Myelodysplastic Neoplasm

Start date: 2025-11-21
Primary completion: 2029-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.